This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.

Rituximab versus cyclophosphamide in connective tissue disease-ILD

  • Research type

    Research Study

  • Full title

    A randomized, double blind controlled trial comparing rituximab against intravenous cyclophosphamide in connective tissue disease associated interstitial lung disease

  • IRAS ID

    98339

  • Contact name

    Toby M Maher

  • Contact email

    t.maher@rbht.nhs.uk

  • Sponsor organisation

    Royal Brompton and Harefield NHS Foundation Trust

  • Eudract number

    2012-003633-42

  • ISRCTN Number

    Not provided

  • Clinicaltrials.gov Identifier

    Not provided

  • REC name

    London - Westminster Research Ethics Committee

  • REC reference

    13/LO/0968

  • Date of REC Opinion

    1 Jul 2013

  • REC opinion

    Favourable Opinion